Antipsychotic Mortality Risk Analysis By Independent Group Needed

Pharmaceutical manufacturers should allow an independent group to analyze their data on antipsychotic drugs to better understand characteristics associated with potential drug-related mortality, researchers suggest in the Oct. 19 Journal of the American Medical Association